Supplementary Table – First-line Osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status

Name: Supplementary Table – First-line Osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status
Creator: Taylor & Francis
Published: 2024-05-16 14:28:23
License: 暂无描述

DataCite Commons2024-05-16 更新2025-04-15 收录

下载链接：

https://tandf.figshare.com/articles/dataset/Supplementary_Table_First-line_Osimertinib_in_EGFR_mutation-positive_non-small_cell_lung_cancer_patients_with_poor_performance_status/16988269/1

下载链接

链接失效反馈

官方服务：

资源简介：

<b>Supplementary Table 1</b>. First-line Osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status <i>The reasons for dose reduction</i>

提供机构：

Taylor & Francis

创建时间：

2021-11-11